• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

AGN simple sales reps making $110K base?

















1. Pfizer will buy you and you'll all be fired with the change in tax inversion laws. Way to keep tax money in America President 45!

2.GI division is a planned failure to get rid of reps earning $100,000 a year just for rolling out of bed. A highly trained, focussed, devoted sales specialized sales team couldn't displace some of the market leaders. You think a bunch of 13 call a day sample droppers can get it done?

3. AGN will be bought out right or each division will be sold off separatelydepending on what makes the boad the most money.

4.With SO MUCH riding in the drug pipeline, 200 less people in R&D makes R&D hard to do.

Ride it out folks. You'll get great severance packages no matter what happens.

So work 3 hour days, take lots of time off and ride it out.
 








NEUROSCIENCE -Botox reps are making well over 100k

Time magazine reported Botox therapeutic sales in 2015 at around $1B+(yes, billion) so a hundred reps are valuable dealing with the product & insurance.

The cosmetic reps take on the other $1B. Cash pay.

Smart move to keep that product going strong. Don't kill the goose!